Document is current
Any future updates will be listed below
-
Authors
Egenlauf, B.
Braun, M.
Schiffer, V.
Marra, A. M.
Xanthouli, P.
Harutyunova, S.
Eichstaedt, C. A.
Erbel, C.
Schell, R.
Linden, F.
Grünig, E.
Benjamin, Nicola
-
Funding
Funding for this research was provided by:
Universitätsklinikum Heidelberg
- License Information
-
More Information
Article History
Received: 26 June 2024
Accepted: 15 May 2025
First Online: 24 June 2025
Declarations
:
: BE: received travel fees, consulting fees, speaking fees, and/or honoraria from Janssen, MSD, Bayer and OMT, outside the submitted work. MB, VS, AMM, CAE, CE, RS, FL, NB: nothing to declare. PX: has received personal fees from MSD and OMT outside the submitted work. SH: received honoraria for lectures, consultancy, or both from Actelion, AOP, Bayer/MSD, GSK, Novartis, OMT, Pfizer, and United Therapeutics outside the submitted work. EG: has received grants and personal fees from Actelion, Bayer AG, and MSD; grants from GSK, Novartis, and United Therapeutics and personal fees from SCOPE, OrPha Swiss GmbH, and Zurich Heart House, outside the submitted work.
